small cell lung cancer

BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
Fierce Biotech
Fri, 03/28/25 - 11:14 am
BioNTech
small cell lung cancer
bispecific antibodies
BNT327
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thu, 01/2/25 - 11:37 am
Roche
China
antibody-drug conjugates
small cell lung cancer
FDA clears AZ's Imfinzi for aggressive lung cancer
Pharmaphorum
Thu, 12/5/24 - 11:10 am
AstraZeneca
Imfinzi
small cell lung cancer
FDA
Zai Lab stock rockets 24% on data for lung cancer ADC drug 39m
MSN/Seeking Alpha
Thu, 10/24/24 - 10:57 am
Zai Lab
ZL-1310
small cell lung cancer
clinical trials
antibody-drug conjugate
Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data
Fierce Biotech
Mon, 09/9/24 - 11:30 am
Merck
Daiichi Sankyo
I-DXd
small cell lung cancer
clinical trials
Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific combo
Fierce Biotech
Tue, 08/6/24 - 11:20 am
Merck
Harpoon Therapeutics
Daiichi Sankyo
small cell lung cancer
Daiichi Sankyo and MSD announce first subject dosing in lung cancer trial
Clinical Trials Arena
Fri, 08/2/24 - 11:50 am
Daiichi Sankyo
Merck
clinical trials
I-DXd
small cell lung cancer
Amgen’s Imdelltra BiTEs into SCLC treatment drought
Clinical Trials Arena
Sun, 07/14/24 - 10:15 pm
Amgen
Imdelltra
small cell lung cancer
BiTEs
FDA approves Amgen drug for small cell lung cancer
Reuters
Thu, 05/16/24 - 09:47 pm
Amgen
tarlatamab
FDA
small cell lung cancer
FDA starts speedy review of Amgen’s lung cancer BiTE therapy
Pharmaphorum
Thu, 12/14/23 - 09:34 am
Amgen
tarlatamab
small cell lung cancer
bispecifics
BiTE
solid tumors
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
Amgen's tarlatamab BiTEs at small cell lung cancer in brief readout
Fierce Biotech
Thu, 08/3/23 - 06:37 pm
Amgen
tarlatamab
small cell lung cancer
T-cells
FDA approves Legend Biotech’s IND application for lung cancer therapy trial
Clinical Trials Arena
Tue, 11/22/22 - 10:58 am
FDA
Legend Biotech
LB2102
small cell lung cancer
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
BioSpace
Thu, 10/27/22 - 08:14 pm
Jazz Pharmaceuticals
FDA
Zepzelca
small cell lung cancer
FDA grants IND clearance for Phase I trials of Phanes’ cancer antibody
Clinical Trials Arena
Mon, 10/17/22 - 10:31 am
Phanes Therapeutics
PT217
FDA
small cell lung cancer
ESMO: Daiichi dazzles in lung cancer to dial up hopes for next ADC
Fierce Biotech
Mon, 09/12/22 - 10:43 am
ESMO
Daiichi Sankyo
DS-7300
small cell lung cancer
PhIII fail in overall survival measure clouds Ipsen's expansion plans for cancer drug Onivyde
Endpoints
Wed, 08/3/22 - 10:51 am
Ipsen
Onivyde
small cell lung cancer
clinical trials
Jazz recognizes less-common small cell lung cancer patients' needs with new online initiative
Fierce Pharma
Mon, 06/21/21 - 10:46 am
Jazz Pharmaceuticals
patient education
small cell lung cancer
Merck follows Bristol's suit, pulling Keytruda's SCLC nod. Is the FDA's accelerated approval reckoning finally here?
Fierce Pharma
Tue, 03/2/21 - 12:14 pm
Merck
Keytruda
FDA
small cell lung cancer
Opdivo
Bristol-Myers Squibb
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Endpoints
Thu, 12/3/20 - 10:52 am
Jazz Pharmaceuticals
lurbinectedin
small cell lung cancer
clinical trials

Pages